Ursprung des Netzwerks ersten Grades von Katrin Tissonnier
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Nextech Invest AG
Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals.
7
| Private Company | Investment Managers | 7 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Katrin Tissonnier
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ImVision Therapeutics, Inc.
ImVision Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ImVision Therapeutics, Inc. develops proprietary technology for the delivery of immunotherapeutics in the treatment of allergies. The company was founded on January 28, 2005 and is headquartered in Hanover, Germany. | Pharmaceuticals: Major | Director/Board Member | |
TRACON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
PMG Investment Solutions AG
PMG Investment Solutions AG Investment ManagersFinance Part of Swiss Pension & Investment Group AG, PMG Investment Solutions AG is an independent Swiss fund management company based in Zurich, Switzerland. With almost 20 years of experience, PMG provides a range of fund management services, including administration and individualized solutions for funds in Switzerland and abroad. The company was founded in 1992, and the CEO is Bernhard Schneider. | Investment Managers | Portfolio Manager-Equities | |
Stanford University | College/University | Undergraduate Degree | |
SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of St. Gallen | College/University | Masters Business Admin | |
Novartis Venture Funds
Novartis Venture Funds Investment ManagersFinance Novartis Venture Funds (NVF) is a venture capital firm with headquarters in Basel, Switzerland and an additional office in Cambridge, MA. The firm was founded in 1996. NVF is a subsidiary of Novartis AG (VX: NOVN) and was created following the 1996 merger of Ciba-Geigy and Sandoz. | Investment Managers | President | |
University of Basel | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
University of Zurich | College/University | Doctorate Degree | |
Friedrich Miescher Institute | College/University | Doctorate Degree | |
BioMedPartners AG
BioMedPartners AG Investment ManagersFinance BioMedPartners AG (BMP), is an independant venture capital firm headquartered in Basel, Switzerland. BMP originated in 2002 as Seed Capital Advisors AG. The firm manages sector-focused venture capital funds including BioMedInvest, BioMedInvest II and BioMedCredit. They specialize in the biomedical sector. | Investment Managers | Private Equity Investor | |
The Genetics Co., Inc.
The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. | Medical/Nursing Services | Director/Board Member President | |
Covagen AG
Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Chairman | |
SynphaBase AG
SynphaBase AG Miscellaneous Commercial ServicesCommercial Services SynphaBase AG provides contract research and development services to the pharmaceutical and chemical industry. Its products and services include route finding and process development, production of multi-kg up to metric tons, lab scale synthesis and carbohydrates and glycans. The firm’s catalogue includes monosaccharides as building blocks for glycan synthesis with various protecting group patterns and linker systems, disaccharides, oligosaccharides, glycosyl amino acids; core structures and building blocks for carbohydrate-based vaccine. The company was founded by in Arthur Bodenmüller in December 2000 and is headquartered in Pratteln, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Creoptix AG
Creoptix AG BiotechnologyHealth Technology Creoptix AG provides biosensor devices for applications in drug discovery. It specializes in optical instruments and consumables for the label-free analysis of molecular interactions for the drug discovery. The firm’s products include instruments, sensors, and software. The company was founded by Kaspar Cottier in 2009 and is headquartered in Wadenswil, Switzerland. | Biotechnology | Chief Executive Officer | |
Medimaps Group SA
Medimaps Group SA Packaged SoftwareTechnology Services Medimaps Group SA designs and provides medical tools. The company is headquartered in Plan-les-Ouates, Switzerland. | Packaged Software | Director/Board Member | |
NLS PHARMACEUTICS AG | Pharmaceuticals: Major | Director/Board Member | |
Julier Partners GmbH | Founder |
Statistik
International
Schweiz | 18 |
Vereinigte Staaten | 3 |
Deutschland | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 6 |
Finance | 4 |
Commercial Services | 3 |
Health Services | 2 |
Operativ
Director/Board Member | 7 |
Private Equity Investor | 5 |
Undergraduate Degree | 3 |
Doctorate Degree | 3 |
Corporate Officer/Principal | 2 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Myoung-Ok Kwon | 10 |
Rudolf Gygax | 9 |
Mátyás Végh | 6 |
Valentin Piëch | 2 |
Peter Mozerov | 1 |
Roland Ruckstuhl | 1 |
Camille Therre | 1 |
- Börse
- Insiders
- Katrin Tissonnier
- Unternehmensverbindungen